Weiss Multi Strategy Advisers LLC Cara Therapeutics, Inc. Transaction History

Weiss Multi Strategy Advisers LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$15.07 - $21.71 $607,818 - $875,629	-40,333 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$12.72 - $16.16 $67,835 - $86,181	5,333 Added 15.24%	40,333 $610,000
Q3 2020 Nov 16, 2020	BUY	$12.34 - $17.92 $121,919 - $177,049	9,880 Added 39.33%	35,000 $445,000
Q2 2020 Aug 14, 2020	BUY	$12.39 - $17.33 $91,500 - $127,982	7,385 Added 41.64%	25,120 $430,000
Q1 2020 May 15, 2020	BUY	$9.12 - $17.78 $70,543 - $137,528	7,735 Added 77.35%	17,735 $234,000
Q4 2019 Feb 14, 2020	BUY	$16.11 - $25.98 $161,100 - $259,800	10,000 New	10,000 $161,000

12.8M

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $16.7M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.